Stimulator, Electrical, Transcutaneous, For Diabetic Retinopathy
OXW is the FDA product code for Stimulator, Electrical, Transcutaneous, For Diabetic Retinopathy. FDA's definition for this code reads: "Electrical stimulation unit with leads and cutaneous electrodes used to apply an electrical current through the electrodes to the patient's eyelid to create a microcurrent loop that flows through the retina". As of , FDA records hold no 510(k) clearances under this code and no recalls.
Classification record
- Product code
- OXW
- Device name
- Stimulator, Electrical, Transcutaneous, For Diabetic Retinopathy
- FDA definition
- Electrical stimulation unit with leads and cutaneous electrodes used to apply an electrical current through the electrodes to the patient's eyelid to create a microcurrent loop that flows through the retina.
- Device class
- Not classified
- Review panel
- Unknown
- Submission type
- Contact ODE
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- No
- Ingested clearances
- 0
- Ingested recalls
- 0
Companies listing this code with FDA
Companies whose registered establishments list this codeNo registered establishment in MDM’s records lists product code OXW.
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
